B. Braun Enhances Safety with New Midazolam Injection Launch
B. Braun's Innovative Midazolam Injection
B. Braun Medical Inc. has unveiled a new product in the U.S. market, Midazolam in 0.8% Sodium Chloride Injection. This innovative introduction reflects B. Braun's commitment to enhancing safety and usability in infusion therapy. The product is preservative-free and comes in two strengths: 50 mg in 50 mL and 100 mg in 100 mL. Both formulations are securely packaged in IV bags that exclude DEHP, PVC, and natural rubber latex, prioritizing safety for both patients and the environment.
Enhanced Features for Improved Usability
Each bag of the Midazolam injection features a robust design including a 2D enhanced barcode. This code encompasses vital information such as the National Drug Code (NDC) number, lot number, and expiration date. Such thorough detailing reflects B. Braun's dedication to making healthcare workflows safer while simultaneously reducing the chances of medication errors.
A Commitment to Quality and Patient Safety
"This new product signifies another significant advancement in our ongoing mission to deliver top-quality, patient-focused solutions," stated Jeremy Greene, the Senior Director of Marketing for IV Fluids and Pharma Injectables. He emphasized the thoughtful design of the product, which integrates preservative-free formulation and advanced packaging solutions, aligning with the needs of both patients and healthcare professionals.
Benefits of Preservative-Free Formulation
The release of the Midazolam in 0.8% Sodium Chloride Injection exemplifies B. Braun's commitment to expanding its portfolio of indispensable injectable medications. This expansion underscores B. Braun's role as a reliable partner in improving healthcare safety and efficacy.
What Sets B. Braun Apart
One distinguishing factor for B. Braun Medical Inc. is its emphasis on innovative technology and sustainable practices. By providing healthcare professionals with high-quality products, B. Braun aims to enhance both patient satisfaction and clinical outcomes. This approach not only supports individual health needs but also contributes to the overarching goal of operational efficiency within healthcare settings.
About B. Braun Medical Inc.
B. Braun Medical Inc. takes pride in being a leader in infusion therapy and pharmacy products. The company is committed to patient and provider safety, offering sustainable health solutions designed to aid healthcare professionals in their critical work. Headquartered in Bethlehem, Pennsylvania, B. Braun operates as part of the broader B. Braun Group, employing over 8,500 individuals across North America and participating extensively in elevating healthcare standards.
Frequently Asked Questions
What is the new product launched by B. Braun?
B. Braun has launched Midazolam in 0.8% Sodium Chloride Injection, designed for improved safety and usability.
What are the key features of the new Midazolam injection?
The injection features preservative-free formulations, a 2D enhanced barcode, and packaging free from DEHP, PVC, or latex.
How long is the shelf life of the new Midazolam product?
The new injection has a shelf life of 36 months, facilitating better inventory management for healthcare facilities.
How does B. Braun ensure patient safety?
B. Braun focuses on quality assurance through innovative product design and advanced safety features to minimize medication errors.
Where is B. Braun headquartered?
B. Braun Medical Inc. is headquartered in Bethlehem, Pennsylvania and is part of the larger B. Braun Group of Companies.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.